Free Trial

Abbott Laboratories (ABT) SEC Filings & 10K Form

Abbott Laboratories logo
$135.18 -0.37 (-0.27%)
As of 05/20/2025 03:59 PM Eastern

Recent Abbott Laboratories SEC Filings

DateFilerForm TypeView
04/29/2025
5:30 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
4:49 PM
Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
4:58 PM
Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
5:06 PM
Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
5:14 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
5:22 PM
Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
4:19 PM
Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
4:30 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2025
4:40 PM
Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
3:10 PM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
6:36 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
4:39 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
4:30 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
4:05 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:55 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:28 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
4:47 PM
Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:54 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 PM
Abbott Laboratories (Issuer)
Shroff Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:05 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:33 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:39 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:44 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:21 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:27 PM
Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:00 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:40 PM
Abbott Laboratories (Subject)
Shroff Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
7:29 PM
Abbott Laboratories (Issuer)
Shroff Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/03/2025
6:58 PM
Abbott Laboratories (Subject)
Moreland Mary K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
7:08 PM
Abbott Laboratories (Subject)
Morrone Louis H. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
7:18 PM
Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
6:52 PM
Abbott Laboratories (Subject)
MCCOY JOHN A. JR. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
5:47 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:56 PM
Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:07 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:17 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:26 PM
Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:35 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:37 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:46 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
4:51 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
02/05/2025
5:52 PM
Abbott Laboratories (Subject)
Ford Robert B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
6:08 PM
Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
6:16 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
6:33 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:33 PM
Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
4:26 PM
Abbott Laboratories (Subject)
Salvadori Daniel Gesua Sive (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
4:30 PM
Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
6:13 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
4:26 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
4:14 PM
Abbott Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2024
4:10 PM
Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
4:27 PM
Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:33 PM
Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:39 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:48 PM
Abbott Laboratories (Issuer)
Stratton John G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
4:24 PM
Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:20 PM
Abbott Laboratories (Subject)
Ford Robert B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:03 PM
Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
6:52 PM
Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:02 PM
Abbott Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2024
6:37 AM
Abbott Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
3:39 PM
Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM
Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:ABT) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners